Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Myocardial Fibrosis

Myocardial Fibrosis

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Myocardial Fibrosis

2 trials tracked for Myocardial Fibrosis: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 77 citations.

2Trials tracked
2Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 2
  1. Phase 4 Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy Completed · 77 cited
  2. Phase 4 Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2 Completed · 42 cited

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systematic review examines programmed cell death roles in myocardial fibrosis mechanisms
Cardiology Sys. Review
Systematic review examines programmed cell death roles in myocardial fibrosis mechanisms Review links cell death types to heart scarring processes
This systematic review investigated the roles of various programmed cell death types in myocardial fibrosis.
Different types of programmed cell death drive heart scarring by activating fibroblasts and altering the heart's structural material, offeri…
Frontiers Apr 9, 2026
Review suggests TWEAK-Fn14 axis contributes to brain injury and cardiac dysfunction pathology
Cardiology Sys. Review
Review suggests TWEAK-Fn14 axis contributes to brain injury and cardiac dysfunction pathology Review explores protein link between brain and heart diseases
A systematic review summarizes evidence on the TWEAK-Fn14 signaling pathway in cardio-cerebrovascular diseases.
High levels of two specific proteins linked to brain swelling and heart scarring may offer a future target for treating brain-heart syndrome…
Frontiers Apr 2, 2026